About Abiomed
Abiomed is a company based in Danvers (United States) founded in 1981 was acquired by Johnson & Johnson in November 2022. The company has 1,157 employees as of December 31, 2021. Abiomed has completed 3 acquisitions, including Breethe, Impella and preCARDIA. Abiomed offers products and services including Impella Heart Pumps and Impella Connect Services.
- Headquarter Danvers, United States
- Employees 1157 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abiomed
-
Annual Revenue
$1.03 B (USD)22as on Mar 31, 2022
-
Net Profit
$136.51 M (USD)-39as on Mar 31, 2022
-
EBITDA
$140.72 M (USD)-39as on Mar 31, 2022
-
Latest Funding Round
$99.67 K (USD), Grant
Aug 09, 2010
-
Investors
Johnson & Johnson
& 2 more
-
Employee Count
1157
as on Dec 31, 2021
-
Investments & Acquisitions
Breethe
& 2 more
-
Acquired by
Johnson & Johnson
(Nov 01, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abiomed
Abiomed offers a comprehensive portfolio of products and services, including Impella Heart Pumps and Impella Connect Services.
Impella heart pumps are employed to deliver temporary circulatory support for patients with heart conditions, facilitating procedures like protected PCI.
Support services are offered to provide clinical assistance and resources that aid health care professionals in managing patient care effectively.
People of Abiomed
Unlock access to complete
Funding Insights of Abiomed
Investors in Abiomed
Abiomed has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Johnson & Johnson, HHS and EW Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Healthcare solutions are provided by Johnson & Johnson globally.
|
Locked | Locked | Locked |
Investor details for Abiomed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Abiomed
Abiomed has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Breethe, Impella and preCARDIA.
Investment portfolio details for Abiomed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A device for treating acute decompensated heart failure is developed.
|
Locked | Locked | 2016 | Locked | |
|
Meditation programs are delivered through a mobile app by Breethe.
|
Locked | Locked | 2014 | Locked | |
|
Ventricular assist devices are provided for cardiac hemodynamic support.
|
Locked | Locked | 1998 | Locked |
Complete acquisition details for Abiomed
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Abiomed
Detailed financials for Abiomed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abiomed Comparisons
Peer comparison for Abiomed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Abiomed
Detailed competitors of Abiomed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abiomed
Complete news archive for Abiomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abiomed
Abiomed was founded in 1981 and raised its 1st funding round 24 years after it was founded.
Abiomed is headquartered in Danvers, United States. It is registered at Danvers, Massachusetts, United States.
As of Dec 31, 2021, the latest employee count at Abiomed is 1,157.
Annual revenue of Abiomed is $1.03B as on Mar 31, 2022.
Abiomed was founded in 1981 and is based in Danvers, United States, within the medical device sector focused on cardiovascular technologies. Operations center on devices that assist heart function, including the Impella heart pump designed for hemodynamic support during procedures. The OXY-1 System is also provided as a portable cardiopulmonary unit with built-in oxygen supply to enable patient mobility. These offerings address needs in cardiac care and circulation management.
Abiomed offers Impella Heart Pumps and Impella Connect Services.
Abiomed has 3 investors. Key investors include Johnson & Johnson, HHS, and EW Healthcare Partners.